Abstract
Summary
Methods involving separate selective destruction of sphingosine and phospholipid antithromboplastin in mixtures of the two indicate that they cannot be the same. Differences in their chemical and biological properties also support the view that they are distinctly different anticoagulants.
Get full access to this article
View all access options for this article.